RALYANT
Dead / Abandoned — Abandoned — no statement of use filed (as of 09 Oct 2025)
What this means for you
This application is over — abandoned 09 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90738229
- Mark type
- Stylized text
- Filed
- 27 May 2021
- Published for opposition
- 04 Jan 2022
- Abandoned
- 09 Oct 2025
- Attorney of record
- Cheryl L. Foytlin
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Owner
- Janssen Sciences Ireland Unlimited Company, Ringaskiddy, Co. Cork, IE
- Janssen Sciences Ireland Unlimited Company, Ringaskiddy, Co. Cork, IE
Prosecution history
- 09 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 09 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 09 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Aug 2024 — SOU EXTENSION 5 GRANTED
- 09 Aug 2024 — SOU EXTENSION 5 FILED
- 09 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 27 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Feb 2024 — SOU EXTENSION 4 GRANTED
- 26 Feb 2024 — SOU EXTENSION 4 FILED
- 26 Feb 2024 — SOU TEAS EXTENSION RECEIVED
- 24 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Aug 2023 — SOU EXTENSION 3 GRANTED
- 22 Aug 2023 — SOU EXTENSION 3 FILED
- 22 Aug 2023 — SOU TEAS EXTENSION RECEIVED
- 25 Feb 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED